BIO254:Gprotein

From OpenWetWare
Jump to navigationJump to search
WIKIPEDIA BIO154/254: Molecular and Cellular Neurobiology

[Course Home]        Wiki Home        People        Materials        Schedule        Help       

Introduction

The term G protein refers to proteins that bind the nucleotide guanine as guanosine triphosphate (GTP) and guanosine diphosphate (GDP). There are two types of G proteins: heterotrimeric, or large, G proteins and small G proteins. Heterotrimeric G proteins are membrane-associated and, along with G protein-coupled receptors (GPCRs), function primarily in cell signalling and signal transduction. Small GTP-binding proteins function in diverse cellular processes including signal transduction, cytoskeletal reorganization, and vesicle trafficking. The small G protein superfamily includes the Ras family (signal transduction), the Rho/Rac family (cytoskeleton), the Rab and Sar1/Arf families (vescicle trafficking), and the Ran family (nuclear import/export) (Takai et al., 2001).

A molecular switch

G protein activity is dependent on whether it is binding GTP or GDP. This useful property has led to the appropriation of G proteins by many cellular processes to be used as "molecular switches". G proteins are generally thought to be "active" when binding GTP and "inactive" when binding GDP. The transition from the GTP-bound state to the GDP-bound state depends on the hydrolysis of GTP. This GTPase activity is either completely intrinsic to the G protein or is enhanced by another class of proteins, "GTPase activating proteins" (GAPs). The GDP to GTP transition requires the dissociation of GDP, so that GTP may again bind at the active site. Proteins that mediate this GDP dissociation are known as guanine nucleotide exchange factors (GEFs).

Heterotrimeric G proteins

Heterotrimeric G proteins consist of three subunits: α, β and γ. Heterotrimeric G proteins exist as a complex (Gαβγ) in the GDP-bound state but dissociate (into Gα and Gβγ) upon the release of GDP and binding of GTP. The α subunit of the G-protein contains the GDP/GTP binding site and GTPase activity (Fig. 2). The C-terminus of the α subunit gives the G protein affinity for specific membrane-bound GPCRs (see below).
Figure 2. Image from (Milligan, 2006). Some parts have been removed for clarity. GDP is shown in purple. The α subunit C-terminus residues, shown in blue, convey GPCR specificity. The N-terminus helix, shown in red, is required for binding of the α subunit to the other subunits.

Discovery

The role of cAMP-dependent signal transduction was known in the 1950s and 1960s; however, the essential role of GTP was masked by the fact that cAMP preparations were contaminated by GTP (Milligan, 2006). In the 1970s a mutated cell line was found to have an intact ligand receptor and amplifier, yet this cell line did not respond to the receptors ligand (Fig. 3a), implying the existence of an intermediary and also providing a cell line on which reconstitution assays could be performed. Alfred G. Gilman purified and identified this intermediary in 1980 (Northup, 1980) by reconstituting the complete pathway by adding a purified protein, the G-protein (Fig. 3b).
Figure 3a. Image modified from http://nobelprize.org/nobel_prizes/medicine/laureates/1994/illpres/disc-gprot.html.
Figure 3b. Image modified from http://nobelprize.org/nobel_prizes/medicine/laureates/1994/illpres/disc-gprot.html.

The heterotrimeric G protein that Gilman isolated increased cAMP levels. In 1980 Martin Rodbell wrote a review (Rodbell, 1980) that helped direct the search for the first cAMP reducing G-protein to be discovered, in 1984. Martin Rodbell and Alfred G. Gilman were awarded the 1994 Nobel Prize in Physiology and Medicine for the discovery of "G-proteins and the role of these proteins in signal transduction in cells". Since the first G-proteins were identified, many others with effectors other than cAMP have been cloned, in many cases by homology. Currently 16 alpha, 5 beta, and 14 gamma subunits have been identified (Milligan, 2006).

G Protein-Coupled Receptors

Heterotrimeric G proteins associate with 7-transmembrane domain receptors called G protein-coupled receptors (GPCRs) at the cell membrane. There are as many as 865 GPCR-encoding genes in humans (Milligan, 2006). Specific GPCRs are recognized by specific G proteins. This recognition is mediated by a sequence at the C-terminus of the G-protein α subunit. For more information on G protein-coupled receptors, see the GPCR wikipedia entry

Mode of Action

Binding to GDP increases the affinity of a G protein for its GPCR. When a G-protein-bound GPCR is activated with the appropriate ligand, the ligand/receptor complex acts as a GEF, allowing the GDP to dissociate and GTP to bind. The G protein then dissociates from the GPCR and the α separates from the β- and γ-subunits which remain bound to one another. Gβγ and Gα-GTP may then activate downstream effectors. Figure 4 is a schematic of this dissociation, specifically for the case of a G-protein with adenylate cyclase as its effector; there are G-proteins with many other different types of effectors (see below). Gα-GTP is shown activating adenylate cyclase, which produces cyclic adenosine monophosphate (cAMP), an important second messenger.
Figure 4. Image modified from Firestein, 2001.

Families

Heterotrimeric G proteins have been divided into four families on the basis of sequence similarity: Gs, Gi, Gq, and G12/13. These four families have been shown to have different, but often overlapping, effects on the cell (Fig. 5) (Neves, 2002).
Figure 5. Image taken from Neves, 2002

Effectors

Heterotrimeric G proteins act through a large range of effectors (Table 1).
Table 1. Effectors, expression patterns of heterotrimeric G proteins. Taken from (Milligan, 2006)

The original GPCR cell signaling pathway described was a Gs protein that activates adenylate cyclase. Certain Gi pathways are characterized by the ability of Gαi to inhibit adenylate cyclase. Gβγ subunits have their own downstream effectors, which include phosphatidylinositol 3-kinase (PI3K). Certain Gq pathways act through inositol trisphosphate (IP3), diacylglycerol (DAG), and protein kinase C (PKC). The Gα12 and Gα13 family effectors include phospholipases.

Roles in the Nervous System

Many heterotrimeric G proteins are specific to certain cell types and tissues (Table 1). Certain heterotrimeric G proteins are expressed specifically in nervous system components including olfactory neurons, CNS ganglia, neuroendocrine cells, astroglia, and retinal rod and cone cells. In the nervous system heterotrimeric G proteins are found in signaling pathways mediated by dopamine, epinephrine, serotonin, glucagon, light, olfactory signals, and other factors. They are involved in taste, vision, affect, arousal, and other functions.

Small G Proteins

Small G proteins are between 25 and 40 kD, which is indeed smaller than the heterotrimeric G proteins, the alpha subunit of which alone is 45 kD. There are over 100 small G proteins spanning five families: Ran, Rab, Ras, Arf, and Rho/Rac.

Roles in the Nervous System

The Rho/Rac family of small GTPases

The Rho family of small G proteins, which includes Rho, Rac, and CDC42, are important effectors that regulate actin dynamics. These proteins are of particular importance at the growth cone, where they mediate growth and collapse in response to chemoattractants and repellents. Axon guidance receptors are directly or indirectly coupled to Rho GEFs and GAPs, which regulate Rho activity. Figure 6 describes the relationship between Rho, Rac, CDC42, Rho GEF/GAPs, and actin (Huber, 2003).
Figure 6. Image taken from Huber, 2003

References

1. Takai Y, Sasaki T, Matozaki T. Small GTP-Binding Proteins. Physiol Rev. 81, 153-208 (2001).

2. Luo L. Rho GTPases in neuronal morphogenesis Nat Rev Neurosci. 1, 173-180 (2000).

3. Milligan G, Kostenis E. Heterotrimeric G-proteins: a short history. Br J Pharmacol. 147 Suppl 1:S46-55 (2006)

4. Northup JK, Sternweis PC, Smigel MD, Schleifer LS, Ross EM, Gilman AG. Purification of the regulatory component of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 77 6516–6520 (1980).

5. Rodbell, M. The role of hormone receptors and GTP regulatory proteins in membrane transduction. Nature 284, 17–22 (1980).

6. Firestein, S. How the olfactory system makes sense of scents. Nature 413, 211-218 (2001)

7. Neves S, Ram P, Iyengar R. G protein pathways. Science 296, 1636-1639 (2002)

8. Huber A, Kolodkin A, Ginty D, Cloutier JF. Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. Ann Rv Neurosci 26, 509-63 (2003)

External Links

Recent updates to the site:

List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

25 April 2024

N    16:42  Flow and Pattern Asymmetries‎‎ 8 changes history +35,099 [Courtneychau‎ (8×)]
     
16:42 (cur | prev) −113 Courtneychau talk contribs (→‎Stokes Flow)
     
16:40 (cur | prev) 0 Courtneychau talk contribs (→‎Stokes Flow)
     
16:38 (cur | prev) +2,735 Courtneychau talk contribs (→‎Fundamentals of Mixing)
     
16:36 (cur | prev) +2,194 Courtneychau talk contribs
     
16:35 (cur | prev) +3,117 Courtneychau talk contribs (→‎Active Mixing Methods)
     
16:34 (cur | prev) +6,877 Courtneychau talk contribs (→‎Passive Mixing Methods)
     
16:34 (cur | prev) +55 Courtneychau talk contribs
N    
16:24 (cur | prev) +20,234 Courtneychau talk contribs (Created page with "{{Template:CHEM-ENG590E}} == Fundamentals of Mixing == Mixing can be described as a physical process through which two or more components are combined in a way such that a uniform distribution is achieved; it is a fundamental unit operation that is needed for a variety of applications. However, due to differences in macroscale and microscale flow phenomenon, mixing occurs differently, and hence, the design and implementation of mixers also differs greatly between the...")
     16:24  CHEM-ENG590E:Wiki Textbook‎‎ 8 changes history +111 [Courtneychau‎ (8×)]
     
16:24 (cur | prev) +44 Courtneychau talk contribs (→‎Chapter 4 - Flow Control and Mixing)
     
16:20 (cur | prev) +67 Courtneychau talk contribs (→‎Chapter 4 - Flow Control and Mixing)
     
16:14 (cur | prev) −36 Courtneychau talk contribs (Undo revision 1114660 by Courtneychau (talk)) Tag: Undo
     
16:14 (cur | prev) +27 Courtneychau talk contribs (Undo revision 1114661 by Courtneychau (talk)) Tag: Undo
     
16:14 (cur | prev) −27 Courtneychau talk contribs (Undo revision 1114662 by Courtneychau (talk)) Tag: Undo
     
16:13 (cur | prev) +27 Courtneychau talk contribs (Undo revision 1114661 by Courtneychau (talk)) Tag: Undo
     
16:11 (cur | prev) −27 Courtneychau talk contribs (→‎Chapter 4 - Flow Control and Mixing)
     
16:11 (cur | prev) +36 Courtneychau talk contribs (→‎Chapter 4 - Flow Control and Mixing)
     11:28  BioMicroCenter:Tecan Freedom Evo diffhist −35 Noelani Kamelamela talk contribs (→‎verrity Chemagic 360)
     11:27 Upload log Noelani Kamelamela talk contribs uploaded a new version of File:Chemagic360.jpg
     00:22  The paper that launched microfluidics - Xi Ning‎‎ 7 changes history +4,723 [Xning098‎ (7×)]
     
00:22 (cur | prev) −97 Xning098 talk contribs
     
00:18 (cur | prev) +14 Xning098 talk contribs (→‎Summary)
     
00:11 (cur | prev) +1 Xning098 talk contribs (→‎Introduction)
     
00:11 (cur | prev) +1 Xning098 talk contribs (→‎Introduction)
     
00:11 (cur | prev) 0 Xning098 talk contribs (→‎References)
     
00:08 (cur | prev) +4 Xning098 talk contribs (→‎Significance)
     
00:07 (cur | prev) +4,800 Xning098 talk contribs

24 April 2024

     22:50  WAKNA:Basics‎‎ 8 changes history +610 [Berthold Drexler‎ (8×)]
     
22:50 (cur | prev) +136 Berthold Drexler talk contribs (→‎Hier finden Sie Literatur für Einsteiger:innen in das Gebiet der Neuroanästhesie)
     
22:47 (cur | prev) +238 Berthold Drexler talk contribs (→‎Neuromonitoring allgemein)
     
22:33 (cur | prev) +151 Berthold Drexler talk contribs (→‎Hier finden Sie Literatur für Einsteiger:innen in das Gebiet der Neuroanästhesie)
     
22:31 (cur | prev) 0 Berthold Drexler talk contribs (→‎Grundlagen, Physiologie & Pharmakologie)
     
22:30 (cur | prev) +1 Berthold Drexler talk contribs (→‎Grundlagen, Physiologie & Pharmakologie)
     
22:30 (cur | prev) +313 Berthold Drexler talk contribs (→‎Grundlagen, Physiologie & Pharmakologie)
     
06:23 (cur | prev) +192 Berthold Drexler talk contribs (→‎Hier finden Sie Literatur für Einsteiger:innen in das Gebiet der Neuroanästhesie)
     
06:21 (cur | prev) −421 Berthold Drexler talk contribs (→‎Sonstige)
     18:35  User:Yanbin Huang‎‎ 2 changes history +25 [Yanbin Huang‎ (2×)]
     
18:35 (cur | prev) +13 Yanbin Huang talk contribs (→‎Peer-Reviewed Publications)
     
18:34 (cur | prev) +12 Yanbin Huang talk contribs (→‎Peer-Reviewed Publications)
     17:49  Hu‎‎ 2 changes history +28 [Hugangqing‎ (2×)]
     
17:49 (cur | prev) +18 Hugangqing talk contribs
     
17:48 (cur | prev) +10 Hugangqing talk contribs
     08:14  "Pick and Place" Assembly of Parts Using PDMS - Amy Lim, Rylie Costello‎‎ 6 changes history +394 [Rcostello‎ (6×)]
     
08:14 (cur | prev) +1 Rcostello talk contribs (→‎"Pick and Place" Methodology)
     
08:13 (cur | prev) −14 Rcostello talk contribs (→‎"Pick and Place" Methodology)
     
08:12 (cur | prev) −1 Rcostello talk contribs (→‎"Pick and Place" Methodology)
     
08:12 (cur | prev) −1 Rcostello talk contribs (→‎"Pick and Place" Methodology)
     
08:12 (cur | prev) +110 Rcostello talk contribs (→‎References)
     
08:11 (cur | prev) +299 Rcostello talk contribs (→‎"Pick and Place" Methodology)
     08:02 Upload log Rcostello talk contribs uploaded File:Pick and Place.mp4

23 April 2024